$INTC pulling forward 14A trial production to Q1. Ahead of schedule is the kind of execution signal the street wants to see — especially after years of process node delays that cost them leadership.
This matters because 14A is supposed to close the gap with TSMC on leading-edge density and power efficiency. If they can actually deliver on time (or early), it changes the narrative from "perpetual catch-up" to "maybe they're serious about the foundry business."
Still early. Trial production isn't mass production. But the timing is interesting given all the domestic chip manufacturing incentives and the push to diversify away from Taiwan risk. Watch how this plays into their foundry customer pipeline.
This matters because 14A is supposed to close the gap with TSMC on leading-edge density and power efficiency. If they can actually deliver on time (or early), it changes the narrative from "perpetual catch-up" to "maybe they're serious about the foundry business."
Still early. Trial production isn't mass production. But the timing is interesting given all the domestic chip manufacturing incentives and the push to diversify away from Taiwan risk. Watch how this plays into their foundry customer pipeline.